Neuroleptic malignant syndrome: Successful treatment with dantrolene and bromocriptine
- 1 July 1983
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 14 (1), 89-90
- https://doi.org/10.1002/ana.410140117
Abstract
A patient with chronic schizophrenia treated with fluphenazine developed neuroleptic malignant syndrome, characterized by fever, obtundation, rigidity, and tremulousness. Hyperthermia and elevated serum creatine kinase were successfully corrected by parenteral treatment with dantrolene. Obtundation, rigidity, and tremulousness responded to high doses of bromocriptine.Keywords
This publication has 9 references indexed in Scilit:
- The Neuroleptic Malignant SyndromeArchives of Internal Medicine, 1982
- Acute Myoglobinuric Renal FailureArchives of Internal Medicine, 1982
- Neuroleptic Drug Level Monitoring in PsychiatryTherapeutic Drug Monitoring, 1982
- Akinetic rnutism from hypothalamic damageNeurology, 1981
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- Malignant HyperthermiaAnesthesiology, 1980
- Catatonic Reactions to High-Potency Neuroleptic DrugsArchives of General Psychiatry, 1977
- Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersNeuropharmacology, 1970